UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications

CNS drugs, 2001, Vol.15 (4), p.287-310

2001

Volltextzugriff (PDF)

Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia

Prostaglandins, leukotrienes and essential fatty acids, 2003-12, Vol.69 (6), p.429-436

2003

Volltextzugriff (PDF)

III.P5 ACP-103 Reduces psychosis without impairing motor function in Parkinson's Disease

Parkinsonism & related disorders, 2006-05, Vol.12, p.31-31

2006

Volltextzugriff (PDF)

S.06.04 Choice of drug to improve cognitive function

European neuropsychopharmacology, 1997-09, Vol.7, p.S90-S90

van Kammen, D.P.

1997

Volltextzugriff (PDF)

Confirmatory factor analysis of the WAIS-R in patients with schizophrenia

Schizophrenia research, 1998-11, Vol.34 (1), p.87-94

1998

Volltextzugriff (PDF)

374. Cigarette smoking and antioxidant status in schizophrenia

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S112-S113

1998

Volltextzugriff (PDF)

Haloperidol attenuates CRF release in the rat: A microdialysis study

Biological psychiatry (1969), 1996-04, Vol.39 (7), p.590-590

1996

Volltextzugriff (PDF)

Validity of facial affect processing tasks in schizophrenia

Archives of clinical neuropsychology, 2000-11, Vol.15 (8), p.759-759

2000

Volltextzugriff (PDF)

High CSF predicts earlier relapse in schizophrenia: Survival analysis

Biological psychiatry (1969), 1994-05, Vol.35 (9), p.702-702

1994

Volltextzugriff (PDF)

190. Membrane deficits in schizophrenia

Biological psychiatry (1969), 2000-04, Vol.47 (8), p.S58-S58

2000

Volltextzugriff (PDF)

411. Blood glutathione peroxidase and symptom severity in schizophrenia

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S123-S123

1998

Volltextzugriff (PDF)

412. Superoxide dismutase and negative symptoms in schizophrenia

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S123-S124

1998

Volltextzugriff (PDF)

A comparison of intramuscular (IM) ziprasidone with IM haloperidol

European psychiatry, 1998, Vol.13 (S4), p.304s-304s

1998

Volltextzugriff (PDF)

Sleep disturbances in schizophrenia: Effects of haloperidol

Schizophrenia research, 1992, Vol.6 (2), p.127-127

van Kammen, D.P.

1992

Volltextzugriff (PDF)

Dopamine turnover in schizophrenia before and after haloperidol withdrawal CSF, plasma, and urine studies

Neuropsychopharmacology (New York, N.Y.), 1996-07, Vol.15 (1), p.75-86

1996

Volltextzugriff (PDF)

Memory and plasma HVA changes in schizophrenia: Are they episode markers?

Schizophrenia research, 1993-04, Vol.9 (2), p.174-174

1993

Volltextzugriff (PDF)

No clinically significant effect of topiramate on haloperidol plasma concentration

European neuropsychopharmacology, 1999-09, Vol.9, p.357-357

1999

Volltextzugriff (PDF)

410. Reduced level of the antioxidant proteins in schizophrenia

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S123-S123

1998

Volltextzugriff (PDF)

276. The role of glutamate and HVA in schizophrenic symptomatology

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S83-S83

1998

Volltextzugriff (PDF)

A decreased serotonergic responsivity in platelets of drug-free schizophrenic patients

Schizophrenia research, 1996-02, Vol.18 (2), p.155-155

1996

Volltextzugriff (PDF)

Increased turnover of platelet phosphatidylinositol in schizophrenia

Prostaglandins, leukotrienes and essential fatty acids, 1992-05, Vol.46 (1), p.39-46

1992

Volltextzugriff (PDF)

Clonidine improves memory function in schizophrenia independently from change in psychosis: Preliminary findings

Schizophrenia research, 1988-11, Vol.1 (6), p.417-423

1988

Volltextzugriff (PDF)

A simplified routine assay for urinary 3-methoxy-4-hydroxyphenylglycol

Biological psychiatry (1969), 1995-05, Vol.37 (9), p.646-646

1995

Volltextzugriff (PDF)

Longitudinal assessment of deficit syndrome characteristics

Schizophrenia research, 1993-04, Vol.9 (2), p.102-102

1993

Volltextzugriff (PDF)

Effects of haloperidol on structure of attention in schizophrenia

Archives of clinical neuropsychology, 1997, Vol.12 (4), p.281-282

1997

Volltextzugriff (PDF)

1 – 25 von 58

Menü

Weitere Dienste

Einstellungen

Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications

Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia

III.P5 ACP-103 Reduces psychosis without impairing motor function in Parkinson's Disease

S.06.04 Choice of drug to improve cognitive function

Confirmatory factor analysis of the WAIS-R in patients with schizophrenia

374. Cigarette smoking and antioxidant status in schizophrenia

Haloperidol attenuates CRF release in the rat: A microdialysis study

Validity of facial affect processing tasks in schizophrenia

High CSF predicts earlier relapse in schizophrenia: Survival analysis

190. Membrane deficits in schizophrenia

411. Blood glutathione peroxidase and symptom severity in schizophrenia

412. Superoxide dismutase and negative symptoms in schizophrenia

A comparison of intramuscular (IM) ziprasidone with IM haloperidol

Sleep disturbances in schizophrenia: Effects of haloperidol

Dopamine turnover in schizophrenia before and after haloperidol withdrawal CSF, plasma, and urine studies

Memory and plasma HVA changes in schizophrenia: Are they episode markers?

No clinically significant effect of topiramate on haloperidol plasma concentration

410. Reduced level of the antioxidant proteins in schizophrenia

276. The role of glutamate and HVA in schizophrenic symptomatology

A decreased serotonergic responsivity in platelets of drug-free schizophrenic patients

Increased turnover of platelet phosphatidylinositol in schizophrenia

Clonidine improves memory function in schizophrenia independently from change in psychosis: Preliminary findings

A simplified routine assay for urinary 3-methoxy-4-hydroxyphenylglycol

Longitudinal assessment of deficit syndrome characteristics

Effects of haloperidol on structure of attention in schizophrenia

Suchergebnisse filtern